The FDA has approved a new antibiotic, Gepotidacin (Blujepa), for treating uncomplicated urinary tract infections (UTIs) in women and girls aged 12 and older.
Medical Daily will always protect your security and privacy. Please read our detailed Privacy Policy
Please do not reply to this email. Click here to adjust your notification preferences or unsubscribe.